東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Reviews on biomarker studies in psyc...

Guest, Paul C.

FindBook

Google Book

Amazon

博客來

Reviews on biomarker studies in psychiatric and neurodegenerative disorders

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Reviews on biomarker studies in psychiatric and neurodegenerative disorders/ edited by Paul C. Guest.
其他作者:	Guest, Paul C.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	xiii, 328 p. :ill., digital ;24 cm.
內容註:	1. The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer's Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer's Disease: Future Perspectives.
Contained By:	Springer eBooks
標題:	Biochemical markers. -
電子資源:	https://doi.org/10.1007/978-3-030-05542-4
ISBN:	9783030055424

Reviews on biomarker studies in psychiatric and neurodegenerative disorders
Reviews on biomarker studies in psychiatric and neurodegenerative disorders[electronic resource] /edited by Paul C. Guest. - Cham :Springer International Publishing :2019. - xiii, 328 p. :ill., digital ;24 cm. - Proteomics, metabolomics, interactomics and systems biology ;1118. - Proteomics, metabolomics, interactomics and systems biology ;1118..

1. The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer's Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer's Disease: Future Perspectives.

This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.

ISBN: 9783030055424

Standard No.: 10.1007/978-3-030-05542-4doiSubjects--Topical Terms:

587592
Biochemical markers.

LC Class. No.: R853.B54 / R485 2019

Dewey Class. No.: 610.28

Reviews on biomarker studies in psychiatric and neurodegenerative disorders
LDR:03251nmm a2200337 a 4500 001 2179671
003 DE-He213
005 20190827110931.0
006 m d
007 cr nn 008maaau
008 191122s2019 gw s 0 eng d
020 $a 9783030055424 $q (electronic bk.)
020 $a 9783030055417 $q (paper)
024 7 $a 10.1007/978-3-030-05542-4 $2 doi
035 $a 978-3-030-05542-4
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.B54 $b R485 2019
072 7 $a PSA $2 bicssc
072 7 $a SCI086000 $2 bisacsh
072 7 $a PSA $2 thema
082 0 4 $a 610.28 $2 23
090 $a R853.B54 $b R454 2019
245 0 0 $a Reviews on biomarker studies in psychiatric and neurodegenerative disorders $h [electronic resource] / $c edited by Paul C. Guest.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiii, 328 p. : $b ill., digital ; $c 24 cm.
490 1 $a Proteomics, metabolomics, interactomics and systems biology ; $v 1118
505 0 $a 1. The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans -- 2. The Role of Biomarkers in Alzheimer's Disease Drug Development -- 3. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic and Environmental Factors -- 4. Lymphocytes, Platelets, Erythrocytes and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis -- 5. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms -- 6. Neuroimaging Studies of Cognitive Function in Schizophrenia -- 7. The Role of Biomarkers in Psychiatry -- 8. Interactome Studies of Psychiatric Disorders -- 9. MicroRNAs in Major Depressive Disorder -- 10. Proteomic Markers for Depression -- 11. Advances in Biomarker Studies in Autism Spectrum Disorders -- 12. Proteomic Investigations of Autism Spectrum Disorder: Past Findings, Current Challenges and Future Prospects -- 13. Role of the Gut Microbiome in Autism Spectrum Disorders -- 14. Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia -- 15. Early Detection and Treatment of Patients with Alzheimer's Disease: Future Perspectives.
520 $a This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.
650 0 $a Biochemical markers. $3 587592
650 0 $a Nervous system $x Degeneration. $3 662113
650 0 $a Mental illness. $3 530000
650 1 4 $a Systems Biology. $3 928020
650 2 4 $a Proteomics. $3 600542
650 2 4 $a Gene Expression. $3 600530
700 1 $a Guest, Paul C. $3 3219137
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Proteomics, metabolomics, interactomics and systems biology ; $v 1118. $3 3385039
856 4 0 $u https://doi.org/10.1007/978-3-030-05542-4
950 $a Biomedical and Life Sciences (Springer-11642)